ZTS · 8-K · 20260806PR000038
Product Launch and Transition
Zoetis Inc. · 2026-08-06 · Importance 31 · Surprise 42 · In source text
Zoetis launched Lenivia and Portela in Canada and the European Union, with both products providing dogs and cats up to three months of osteoarthritis pain relief from a single injection. Lenivia was also approved in Switzerland, while both products were approved in Great Britain. Additional approvals expanded Zoetis' animal-health portfolio across poultry, cattle, cats, swine and poultry disease prevention. The pipeline includes more than 12 potential blockbuster candidates in chronic kidney disease, oncology, cardiology, anxiety and obesity.
Key facts
- Lenivia and Portela launched in Canada and the EU and were approved in Great Britain; Lenivia was also approved in Switzerland. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | probable | — | Lenivia and Portela launched in Canada and the EU and were approved in Great Britain; Lenivia was also approved in Switzerland. |